Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mary Jo Tozzi"'
Autor:
Vijay Nandi, Jeffrey Hsu, Joshua Boverman, Mary Jo Tozzi, Linda Weiss, David Hersh, David A. Fiellin, P. Todd Korthuis, Frederick L. Altice, Michael Botsko, James E. Egan, Angela Acosta, Marc N. Gourevitch
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 56:S39-S45
Opioid dependence and HIV infection are associated with poor health-related quality of life (HRQOL). Buprenorphine/naloxone (bup/nx) provided in HIV care settings may improve HRQOL.We surveyed 289 HIV-infected opioid-dependent persons treated with cl
Autor:
Rongwei Fu, Steven M. Asch, David A. Fiellin, Paula J. Lum, P. Todd Korthuis, Margaret Fishl, Mary Jo Tozzi, Joshua Boverman, Frederick L. Altice, Nancy L. Sohler, Timothy P. Flanigan, Michael Botsko, Dennis McCarty
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 56:S83-S90
Background: Opioid-dependent HIV-infected patients are less likely to receive HIV quality of care indicators (QIs) compared with nondependent patients. Buprenorphine/naloxone maintenance therapy (bup/nx) could affect the quality of HIV care for opioi
Autor:
Michael Botsko, Pamela Vergara-Rodriguez, James E. Egan, Vijay Nandi, Mary Jo Tozzi, Lynn E. Sullivan, Frederick L. Altice, Patrick G. O'Connor, David A. Fiellin
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 56
Background: The safety of buprenorphine/naloxone (bup/nx) in HIV-infected patients has not been established. Prior reports raise concern about hepatotoxicity and interactions with atazanavir. Methods: We conducted a prospective cohort study of 303 op
Autor:
Patrick G. OʼConnor, Mary Jo Tozzi, Lynn E. Sullivan, Pamela Vergara-Rodriguez, Frederick L. Altice, Vijay Nandi, Michael Botsko, James E. Egan, David A. Fiellin
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 58:e112-e113